| SScPAH+ N = 11 | SScPAH- N = 13 | Control N = 10 |
---|---|---|---|
FVC, % pred | 97.5 ± 20.8†| 103.0 ± 22.4 | 122.1 ± 17.0 |
FEV1, % pred | 83.5 ± 12.1†| 92.5 ± 20.4 | 108 ± 12.4 |
FEV1/VC | 69.4 ± 9.8 | 72.8 ± 7.0 | 74.2 ± 6.3 |
TLC, % pred | 90.3 ± 17.1 | 91.4 ± 13.6 |  |
TLCO, % pred | 40.7 ± 6.8* †| 63.3 ± 11.7‡ | 93.3 ± 15.0 |
Dm, mmol·min-1·kPA-1 | 3.7 ± 1.1* †| 7.5 ± 2.8‡ | 15.1 ± 4.1 |
Dm,% pred | 21.7 ± 5.8* †| 39.2 ± 12.4‡ | 81.3 ± 18.0 |
Vc, ml | 40.2 ± 14.30 | 45.8 ± 13.7 | 56.2 ± 16.1 |
Vc, % pred | 59.9 ± 24.6†| 61.7 ± 17.6‡ | 82.8 ± 10.8 |
Dm%/Vc % | 0.41 ± 0.25†| 0.71 ± 0.37 | 1.00 ± 0.26 |
Vc%/Dm % | 2.99 ± 1.5* †| 1.73 ± 0.74 | 1.06 ± 0.26 |